AstraZeneca hiked its dividend to persuade shareholders to accept CEO Pascal Soriot’s pay rise. Is he worth his salary?
AstraZeneca CEO’s £1.8mn pay rise approved despite shareholder opposition
Read Also
- Stock Market Today: Wall Street hits pause on searing May rally
- What's Going On With Applied Materials Stock Today?
- Foreigners sell Indian stocks on election risks, China appeal
- India benefiting with increased investments amidst decline in China: UN expert
- Top Crypto Trader Dumps Entire Bitcoin Portfolio To Buy Altcoins, But Should You Be Taking This 'Huge' Risk
- Equinor Reportedly Scores Final Permit, Empire Wind 1 To Blast Off In 2026
- China Gains 1%, Europe Markets Dip, And Gold Inches Toward $2,400 Again - Global Markets Today While US Slept
- Microsoft Unveils AMD-Powered AI Chips To Rival Nvidia: Report
- 'Looking Forward:' SpaceX CEO Elon Musk Blasts Off To Indonesia In Debut Visit For Starlink Launch
- Sam Altman Says He Celebrated Returning To OpenAI After Brief Ouster With Four Heavy Entrees And Two Milkshakes 'Just For Me'
Latest MoneyWeek
- Buying a property is cheaper than renting again – how much could you save?
- Is now a good time to invest in India?
- Is the London Stock Exchange in peril?
- Finfluencer crackdown: Love Island and Towie stars among those charged for unauthorised trading schemes
- Flight prices could rise due to aircraft shortages – is aerospace in trouble?
- US hits Chinese EVs with 100% tariffs
- Shein prepares for London Stock Exchange listing
- Investing in property: why it is still a good diversifier for the long-term
- The areas worst-hit by the furnished holiday lets tax clampdown
- Ofgem considers lifting ban on cheaper energy deals for new customers